OOIR: Observatory of International Research

Papers

(The H4-Index of Harm Reduction Journal is 28. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)

Article	Citations
Decentralized HIV testing: comparing peer and mail-based distribution strategies to improve the reach of HIV self-testing among people who use drugs in Florida	124
Expanding single-venue services to better engage young people who inject drugs: insights from India	107
Egocentric network characteristics of people who inject drugs in the Chicago metro area and associations with hepatitis C virus and injection risk behavior	68
Contamination of a drug consumption room with drugs and potential risks for social health care workers	63
Welfare first: transforming harm reduction at UK festivals	55
Moving from ‘stigma reduction’ to ‘inclusion’: development of the inclusion collaborative at Nepean Blue Mountains Local Health District, New South Wales	52
The impact of institutionalization on the effectiveness of harm reduction: a qualitative study using drug users’ representations	52
Nasal administration of diacetylmorphine improved the adherence in a patient receiving heroin-assisted treatment	50
Assessment of two brands of fentanyl test strips with 251 synthetic opioids reveals “blind spots” in detection capabilities	48
Decolonizing drug policy	47
“The people who depended on us became expendable”: Experiences of frontline workers with lived and living expertise of drug use during the COVID-19 pandemic	46
A mixed-methods analysis of risk-reduction strategies adopted by syringe services program participants and non-syringe services program participants in New York City	45
The acceptability of overdose alert and response technologies: introducing the TPOM-ODART framework	44
HIV risk and prevention among clients of a delivery-based harm reduction service during an HIV outbreak among people who use drugs in northern rural Minnesota, USA	42
Associations with experience of non-fatal opioid overdose in British Columbia, Canada: a repeated cross sectional survey study	41
Fentanyl harm reduction strategies among Latinx communities in the United States: a scoping review	40
Experiences of harm and mental ill-health among gay, bisexual and other men-who-have-sex-with-men who use methamphetamine or GHB/GBL in different combinations: findings from the COMeT study in Taiwan	39
Managed alcohol: one community’s innovative response to risk management during COVID-19	39
Willingness to use and distribute HIV self-testing kits among people who inject drugs in the San Diego–Tijuana border region	38
Exploring perceived quality of life in long-term methadone-dependent patients: a qualitative study	38
Acceptability of supervised injection facilities among persons who inject drugs in upstate New York	32
Barriers to uptake of harm reduction techniques for GBMSM who use drugs in night-clubs and sex-on-premises venues in London and the Southeast: a mixed-methods, qualitative study	31
Facilitators of and obstacles to practitioners’ adoption of harm reduction in cannabis use: a scoping review	30
The implementation of safer drug consumption facilities in Scotland: a mixed methods needs assessment and feasibility study for the city of Edinburgh	30
Vaping among Norwegians who smoke or formerly smoked: reasons, patterns of use, and smoking cessation activity	29

First results of the French OCTOPUS survey among festival attendees: a latent class analysis	29
Strategies used to reduce harms associated with fentanyl exposure among rural people who use drugs: multi-site qualitative findings from the rural opioid initiative	28
Improving access to HIV care among people who inject drugs through tele-harm reduction: a qualitative analysis of perceived discrimination and stigma	28
Harm reduction in substance use: perspectives and experiences of community volunteers and student interns in Durban, South Africa	28